Those results of cyclopamine- (Figures 3B and 3C), GLI1 siRNA- (Figure 4A), and SIP1 siRNA (Figure 4B)-treatment suggested that some mesenchymal phenotypes in diffuse-type GC was exhibited by an EMT regulator SIP1 through Hh signalling. The gene discussed is GLI1; the disease is gastric cancer.